The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines.
Saved in:
| Title: | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines. |
|---|---|
| Authors: | Kim D; Janssen Pharmaceuticals, Titusville, NJ, USA., Robertson JS; Independent Adviser, United Kingdom., Excler JL; International Vaccine Institute, Seoul, Republic of Korea., Condit RC; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA., Fast PE; International AIDS Vaccine Initiative, New York, NY 10004, USA; Stanford School of Medicine, Palo Alto, CA 94305, USA., Gurwith M; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA., Pavlakis G; National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Monath TP; Crozet BioPharma LLC, Devens, MA 01434, USA., Smith J; VLP Therapeutics, Gaithersburg, MD 20878, USA., Wood D; Independent Adviser, United Kingdom., Smith ER; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA., Chen RT; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA., Kochhar S; Global Healthcare Consulting, New Delhi, India; University of Washington, Seattle, WA 98195, USA. |
| Corporate Authors: | Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) |
| Source: | Vaccine [Vaccine] 2020 Jul 22; Vol. 38 (34), pp. 5556-5561. Date of Electronic Publication: 2020 Jun 19. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
